cb5 Search Results


93
Addgene inc er addgene plasmid 18000
Er Addgene Plasmid 18000, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/er addgene plasmid 18000/product/Addgene inc
Average 93 stars, based on 1 article reviews
er addgene plasmid 18000 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Tocris psb cb5 tocris
Psb Cb5 Tocris, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/psb cb5 tocris/product/Tocris
Average 93 stars, based on 1 article reviews
psb cb5 tocris - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
Tocris psb cb5
GPR18-GPR55 interaction in the DHA-DA cytotoxicity. ( A ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 with and without the GPR18 blocker <t>PSB</t> <t>CB5</t> (3 µM). ( B ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 and the variants with knockout GPR55, incubation time 24 h, MTT test data. Pooled data from 7 experiments; mean ± standard error.
Psb Cb5, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/psb cb5/product/Tocris
Average 94 stars, based on 1 article reviews
psb cb5 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

93
Addgene inc backbone plasmid
GPR18-GPR55 interaction in the DHA-DA cytotoxicity. ( A ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 with and without the GPR18 blocker <t>PSB</t> <t>CB5</t> (3 µM). ( B ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 and the variants with knockout GPR55, incubation time 24 h, MTT test data. Pooled data from 7 experiments; mean ± standard error.
Backbone Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/backbone plasmid/product/Addgene inc
Average 93 stars, based on 1 article reviews
backbone plasmid - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

92
Novus Biologicals rat anti perforin
GPR18-GPR55 interaction in the DHA-DA cytotoxicity. ( A ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 with and without the GPR18 blocker <t>PSB</t> <t>CB5</t> (3 µM). ( B ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 and the variants with knockout GPR55, incubation time 24 h, MTT test data. Pooled data from 7 experiments; mean ± standard error.
Rat Anti Perforin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat anti perforin/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
rat anti perforin - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

93
Addgene inc gst keima cb5
GPR18-GPR55 interaction in the DHA-DA cytotoxicity. ( A ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 with and without the GPR18 blocker <t>PSB</t> <t>CB5</t> (3 µM). ( B ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 and the variants with knockout GPR55, incubation time 24 h, MTT test data. Pooled data from 7 experiments; mean ± standard error.
Gst Keima Cb5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gst keima cb5/product/Addgene inc
Average 93 stars, based on 1 article reviews
gst keima cb5 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

91
Addgene inc gst rfp cb5
GPR18-GPR55 interaction in the DHA-DA cytotoxicity. ( A ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 with and without the GPR18 blocker <t>PSB</t> <t>CB5</t> (3 µM). ( B ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 and the variants with knockout GPR55, incubation time 24 h, MTT test data. Pooled data from 7 experiments; mean ± standard error.
Gst Rfp Cb5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gst rfp cb5/product/Addgene inc
Average 91 stars, based on 1 article reviews
gst rfp cb5 - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

91
Addgene inc gst lscs gfp cb5
CALCOCO1 has a role in reticulophagy. (A) <t>GSTLSCSGFP-cb5</t> reticulophagy assay in HEK293 control and 2 sgCALCOCO1 KO cell lines, treated with Veh, 100 nM MLN, or glucose (Glc) starved. <t>GST-tagged</t> proteins/peptides in cell lysates were captured by glutathione agarose affinity purification. Ratio of the bottom fragment to the full-length fusion protein is shown, normalized to MLN in control cells. CALCOCO1 in cell lysates is shown. “B2” and “C3” represent different targets for guide RNA. *nonspecific fragment (B) GSTLSCSGFP-cb5 reticulophagy assay in HEK293 control and sgCALCOCO1 KO cells, treated with Veh, MLN, 10 ug/ml tunicamycin (Tun), or with galactose (Gal). Top panel. GST-tagged proteins/peptides in the LMF. Ratio of the bottom fragment to the full-length fusion protein is shown, normalized to MLN in control cells. Bottom panel. Immunoblot analyses of CALCOCO1 in LMF and high-speed supernatant (HSS) fractions. *nonspecific fragment (C) Immunoblot analysis of GST-Keima-cb5 assay in HEK293 cells, treated with Veh, MLN, and 5 ug/ml Tun as labeled. Ratio of 25 kD fragment to the full-length fusion protein is shown, normalized to MLN in control cells. (D) Relative protein abundances in sgCALCOCO1 KO HEK293 cells compared to sgGFP <t>(GFP)</t> control WT cells (mean, n = 5). Cells were treated for 24 h with 100 nM MLN0128. Proteins were quantified by label-free mass spectrometry. P-values for the protein abundance changes were determined by a two-sided Student’s t-test. (E) GST-BHMT autophagy assay in control and sgCALCOCO1 KO clones, with treatments as in Figure 6A. Ratio of BHMT fragment to GFP, normalized to MLN in control cells, is shown. Immunoblots were probed with antibodies as described. (F) Immunoblot analysis of WT MB231 and 3 sgCALCOCO1 KO cell lines, with antibodies, as shown. Cells were treated for 48 h with Veh, 100 nM MLN, and 20 nM bafilomycin A1, as shown
Gst Lscs Gfp Cb5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gst lscs gfp cb5/product/Addgene inc
Average 91 stars, based on 1 article reviews
gst lscs gfp cb5 - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

93
Proteintech venus tagged cyb5r4 wild type
A) Holoenzyme composition and regulators of PP2A-like phosphatases. B) Schematic of genome-wide CRISPR-Cas9 screen for genes whose knockout are synthetic lethal with okadaic acid (OA). NGS, next-generation sequencing. C) DrugZ analysis of CRISPR-Cas9 synthetic lethality screen performed in RPE1 p53-/-cells comparing treatment with a low dose of OA (2 nM) and untreated conditions. The top genes are indicated with established PP2A-like holoenzyme components and regulators in black and candidate regulators in grey. Significance threshold ( p -value of 0.05) is indicated with a dotted line at a DrugZ score of −3.3. PPP1CA is indicated as highest scoring non PP2A-like phosphatase. D) Human <t>CYB5R4</t> and yeast Irc21 domain organization. Cytb5, cytochrome B5 domain. CS, CHORD/SGT domain. Cytb5-R, Cytochrome b5 reductase domain. E) Profiling of PPP composition by phosphatase inhibitor beads and mass spectrometry (PIB-MS). Volcano plot comparing the phosphatase components captured on phosphatase inhibitor beads from U2OS CYB5R4 knockout (KO) and parental (PAR) cells. PP2A holoenzyme components are indicated in green, PP4 in blue and PP6 in pink. ‘C’ indicates catalytic subunit. F) Peptide dephosphorylation assays measuring the activity of 3xFLAG-tagged PP2A C, PP4 C, and PP6 C, immunopurified from U2OS parental or CYB5R4 knockout stable cell lines. The data is representative of three independent experiments. G) Peptide dephosphorylation assays measuring the activity of HA-Pph21, myc-Pph3, and HA-Sit4 immunopurified from endogenously tagged wildtype ( wt ) and irc21 deletion strains. Data is shown for three independent experiments, and error bars represent standard deviations.
Venus Tagged Cyb5r4 Wild Type, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/venus tagged cyb5r4 wild type/product/Proteintech
Average 93 stars, based on 1 article reviews
venus tagged cyb5r4 wild type - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

88
Addgene inc flag cb5
A) Holoenzyme composition and regulators of PP2A-like phosphatases. B) Schematic of genome-wide CRISPR-Cas9 screen for genes whose knockout are synthetic lethal with okadaic acid (OA). NGS, next-generation sequencing. C) DrugZ analysis of CRISPR-Cas9 synthetic lethality screen performed in RPE1 p53-/-cells comparing treatment with a low dose of OA (2 nM) and untreated conditions. The top genes are indicated with established PP2A-like holoenzyme components and regulators in black and candidate regulators in grey. Significance threshold ( p -value of 0.05) is indicated with a dotted line at a DrugZ score of −3.3. PPP1CA is indicated as highest scoring non PP2A-like phosphatase. D) Human <t>CYB5R4</t> and yeast Irc21 domain organization. Cytb5, cytochrome B5 domain. CS, CHORD/SGT domain. Cytb5-R, Cytochrome b5 reductase domain. E) Profiling of PPP composition by phosphatase inhibitor beads and mass spectrometry (PIB-MS). Volcano plot comparing the phosphatase components captured on phosphatase inhibitor beads from U2OS CYB5R4 knockout (KO) and parental (PAR) cells. PP2A holoenzyme components are indicated in green, PP4 in blue and PP6 in pink. ‘C’ indicates catalytic subunit. F) Peptide dephosphorylation assays measuring the activity of 3xFLAG-tagged PP2A C, PP4 C, and PP6 C, immunopurified from U2OS parental or CYB5R4 knockout stable cell lines. The data is representative of three independent experiments. G) Peptide dephosphorylation assays measuring the activity of HA-Pph21, myc-Pph3, and HA-Sit4 immunopurified from endogenously tagged wildtype ( wt ) and irc21 deletion strains. Data is shown for three independent experiments, and error bars represent standard deviations.
Flag Cb5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flag cb5/product/Addgene inc
Average 88 stars, based on 1 article reviews
flag cb5 - by Bioz Stars, 2026-04
88/100 stars
  Buy from Supplier

90
CARBOMER INC hair color base cb5
A) Holoenzyme composition and regulators of PP2A-like phosphatases. B) Schematic of genome-wide CRISPR-Cas9 screen for genes whose knockout are synthetic lethal with okadaic acid (OA). NGS, next-generation sequencing. C) DrugZ analysis of CRISPR-Cas9 synthetic lethality screen performed in RPE1 p53-/-cells comparing treatment with a low dose of OA (2 nM) and untreated conditions. The top genes are indicated with established PP2A-like holoenzyme components and regulators in black and candidate regulators in grey. Significance threshold ( p -value of 0.05) is indicated with a dotted line at a DrugZ score of −3.3. PPP1CA is indicated as highest scoring non PP2A-like phosphatase. D) Human <t>CYB5R4</t> and yeast Irc21 domain organization. Cytb5, cytochrome B5 domain. CS, CHORD/SGT domain. Cytb5-R, Cytochrome b5 reductase domain. E) Profiling of PPP composition by phosphatase inhibitor beads and mass spectrometry (PIB-MS). Volcano plot comparing the phosphatase components captured on phosphatase inhibitor beads from U2OS CYB5R4 knockout (KO) and parental (PAR) cells. PP2A holoenzyme components are indicated in green, PP4 in blue and PP6 in pink. ‘C’ indicates catalytic subunit. F) Peptide dephosphorylation assays measuring the activity of 3xFLAG-tagged PP2A C, PP4 C, and PP6 C, immunopurified from U2OS parental or CYB5R4 knockout stable cell lines. The data is representative of three independent experiments. G) Peptide dephosphorylation assays measuring the activity of HA-Pph21, myc-Pph3, and HA-Sit4 immunopurified from endogenously tagged wildtype ( wt ) and irc21 deletion strains. Data is shown for three independent experiments, and error bars represent standard deviations.
Hair Color Base Cb5, supplied by CARBOMER INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hair color base cb5/product/CARBOMER INC
Average 90 stars, based on 1 article reviews
hair color base cb5 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


GPR18-GPR55 interaction in the DHA-DA cytotoxicity. ( A ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 with and without the GPR18 blocker PSB CB5 (3 µM). ( B ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 and the variants with knockout GPR55, incubation time 24 h, MTT test data. Pooled data from 7 experiments; mean ± standard error.

Journal: International Journal of Molecular Sciences

Article Title: The Mechanisms of GPR55 Receptor Functional Selectivity during Apoptosis and Proliferation Regulation in Cancer Cells

doi: 10.3390/ijms24065524

Figure Lengend Snippet: GPR18-GPR55 interaction in the DHA-DA cytotoxicity. ( A ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 with and without the GPR18 blocker PSB CB5 (3 µM). ( B ) Cytotoxicity of DHA-DA for the original line MDA-MB-231 and the variants with knockout GPR55, incubation time 24 h, MTT test data. Pooled data from 7 experiments; mean ± standard error.

Article Snippet: SR 144028, PSB CB5, ML-184, ML-193, and LPI were obtained from Tocris Bioscience, Bristol, UK.

Techniques: Knock-Out, Incubation

Cytotoxicity of DHA-DA for the original cell line MDA-MB-231, cells in the presence GPR18 blocker  PSB CB5  (3 µM) and the variant of with knockout GPR55, incubation time 24 h, MTT test data.

Journal: International Journal of Molecular Sciences

Article Title: The Mechanisms of GPR55 Receptor Functional Selectivity during Apoptosis and Proliferation Regulation in Cancer Cells

doi: 10.3390/ijms24065524

Figure Lengend Snippet: Cytotoxicity of DHA-DA for the original cell line MDA-MB-231, cells in the presence GPR18 blocker PSB CB5 (3 µM) and the variant of with knockout GPR55, incubation time 24 h, MTT test data.

Article Snippet: SR 144028, PSB CB5, ML-184, ML-193, and LPI were obtained from Tocris Bioscience, Bristol, UK.

Techniques: Variant Assay, Knock-Out, Incubation

CALCOCO1 has a role in reticulophagy. (A) GSTLSCSGFP-cb5 reticulophagy assay in HEK293 control and 2 sgCALCOCO1 KO cell lines, treated with Veh, 100 nM MLN, or glucose (Glc) starved. GST-tagged proteins/peptides in cell lysates were captured by glutathione agarose affinity purification. Ratio of the bottom fragment to the full-length fusion protein is shown, normalized to MLN in control cells. CALCOCO1 in cell lysates is shown. “B2” and “C3” represent different targets for guide RNA. *nonspecific fragment (B) GSTLSCSGFP-cb5 reticulophagy assay in HEK293 control and sgCALCOCO1 KO cells, treated with Veh, MLN, 10 ug/ml tunicamycin (Tun), or with galactose (Gal). Top panel. GST-tagged proteins/peptides in the LMF. Ratio of the bottom fragment to the full-length fusion protein is shown, normalized to MLN in control cells. Bottom panel. Immunoblot analyses of CALCOCO1 in LMF and high-speed supernatant (HSS) fractions. *nonspecific fragment (C) Immunoblot analysis of GST-Keima-cb5 assay in HEK293 cells, treated with Veh, MLN, and 5 ug/ml Tun as labeled. Ratio of 25 kD fragment to the full-length fusion protein is shown, normalized to MLN in control cells. (D) Relative protein abundances in sgCALCOCO1 KO HEK293 cells compared to sgGFP (GFP) control WT cells (mean, n = 5). Cells were treated for 24 h with 100 nM MLN0128. Proteins were quantified by label-free mass spectrometry. P-values for the protein abundance changes were determined by a two-sided Student’s t-test. (E) GST-BHMT autophagy assay in control and sgCALCOCO1 KO clones, with treatments as in Figure 6A. Ratio of BHMT fragment to GFP, normalized to MLN in control cells, is shown. Immunoblots were probed with antibodies as described. (F) Immunoblot analysis of WT MB231 and 3 sgCALCOCO1 KO cell lines, with antibodies, as shown. Cells were treated for 48 h with Veh, 100 nM MLN, and 20 nM bafilomycin A1, as shown

Journal: Autophagy

Article Title: Mass spectrometry proteomics reveals a function for mammalian CALCOCO1 in MTOR-regulated selective autophagy

doi: 10.1080/15548627.2020.1719746

Figure Lengend Snippet: CALCOCO1 has a role in reticulophagy. (A) GSTLSCSGFP-cb5 reticulophagy assay in HEK293 control and 2 sgCALCOCO1 KO cell lines, treated with Veh, 100 nM MLN, or glucose (Glc) starved. GST-tagged proteins/peptides in cell lysates were captured by glutathione agarose affinity purification. Ratio of the bottom fragment to the full-length fusion protein is shown, normalized to MLN in control cells. CALCOCO1 in cell lysates is shown. “B2” and “C3” represent different targets for guide RNA. *nonspecific fragment (B) GSTLSCSGFP-cb5 reticulophagy assay in HEK293 control and sgCALCOCO1 KO cells, treated with Veh, MLN, 10 ug/ml tunicamycin (Tun), or with galactose (Gal). Top panel. GST-tagged proteins/peptides in the LMF. Ratio of the bottom fragment to the full-length fusion protein is shown, normalized to MLN in control cells. Bottom panel. Immunoblot analyses of CALCOCO1 in LMF and high-speed supernatant (HSS) fractions. *nonspecific fragment (C) Immunoblot analysis of GST-Keima-cb5 assay in HEK293 cells, treated with Veh, MLN, and 5 ug/ml Tun as labeled. Ratio of 25 kD fragment to the full-length fusion protein is shown, normalized to MLN in control cells. (D) Relative protein abundances in sgCALCOCO1 KO HEK293 cells compared to sgGFP (GFP) control WT cells (mean, n = 5). Cells were treated for 24 h with 100 nM MLN0128. Proteins were quantified by label-free mass spectrometry. P-values for the protein abundance changes were determined by a two-sided Student’s t-test. (E) GST-BHMT autophagy assay in control and sgCALCOCO1 KO clones, with treatments as in Figure 6A. Ratio of BHMT fragment to GFP, normalized to MLN in control cells, is shown. Immunoblots were probed with antibodies as described. (F) Immunoblot analysis of WT MB231 and 3 sgCALCOCO1 KO cell lines, with antibodies, as shown. Cells were treated for 48 h with Veh, 100 nM MLN, and 20 nM bafilomycin A1, as shown

Article Snippet: Recombinant proteins GST-BHMT-IRES-GFP and GST LSCS GFP-cb5 have been previously described [ 39 , 59 ] (Addgene, 104442 and 104453; deposited by Carol Mercer).

Techniques: Affinity Purification, Western Blot, Labeling, Mass Spectrometry, Clone Assay

A) Holoenzyme composition and regulators of PP2A-like phosphatases. B) Schematic of genome-wide CRISPR-Cas9 screen for genes whose knockout are synthetic lethal with okadaic acid (OA). NGS, next-generation sequencing. C) DrugZ analysis of CRISPR-Cas9 synthetic lethality screen performed in RPE1 p53-/-cells comparing treatment with a low dose of OA (2 nM) and untreated conditions. The top genes are indicated with established PP2A-like holoenzyme components and regulators in black and candidate regulators in grey. Significance threshold ( p -value of 0.05) is indicated with a dotted line at a DrugZ score of −3.3. PPP1CA is indicated as highest scoring non PP2A-like phosphatase. D) Human CYB5R4 and yeast Irc21 domain organization. Cytb5, cytochrome B5 domain. CS, CHORD/SGT domain. Cytb5-R, Cytochrome b5 reductase domain. E) Profiling of PPP composition by phosphatase inhibitor beads and mass spectrometry (PIB-MS). Volcano plot comparing the phosphatase components captured on phosphatase inhibitor beads from U2OS CYB5R4 knockout (KO) and parental (PAR) cells. PP2A holoenzyme components are indicated in green, PP4 in blue and PP6 in pink. ‘C’ indicates catalytic subunit. F) Peptide dephosphorylation assays measuring the activity of 3xFLAG-tagged PP2A C, PP4 C, and PP6 C, immunopurified from U2OS parental or CYB5R4 knockout stable cell lines. The data is representative of three independent experiments. G) Peptide dephosphorylation assays measuring the activity of HA-Pph21, myc-Pph3, and HA-Sit4 immunopurified from endogenously tagged wildtype ( wt ) and irc21 deletion strains. Data is shown for three independent experiments, and error bars represent standard deviations.

Journal: bioRxiv

Article Title: A functional map of phosphoprotein phosphatase regulation identifies an evolutionary conserved reductase for the catalytic metal ions

doi: 10.1101/2025.02.12.637884

Figure Lengend Snippet: A) Holoenzyme composition and regulators of PP2A-like phosphatases. B) Schematic of genome-wide CRISPR-Cas9 screen for genes whose knockout are synthetic lethal with okadaic acid (OA). NGS, next-generation sequencing. C) DrugZ analysis of CRISPR-Cas9 synthetic lethality screen performed in RPE1 p53-/-cells comparing treatment with a low dose of OA (2 nM) and untreated conditions. The top genes are indicated with established PP2A-like holoenzyme components and regulators in black and candidate regulators in grey. Significance threshold ( p -value of 0.05) is indicated with a dotted line at a DrugZ score of −3.3. PPP1CA is indicated as highest scoring non PP2A-like phosphatase. D) Human CYB5R4 and yeast Irc21 domain organization. Cytb5, cytochrome B5 domain. CS, CHORD/SGT domain. Cytb5-R, Cytochrome b5 reductase domain. E) Profiling of PPP composition by phosphatase inhibitor beads and mass spectrometry (PIB-MS). Volcano plot comparing the phosphatase components captured on phosphatase inhibitor beads from U2OS CYB5R4 knockout (KO) and parental (PAR) cells. PP2A holoenzyme components are indicated in green, PP4 in blue and PP6 in pink. ‘C’ indicates catalytic subunit. F) Peptide dephosphorylation assays measuring the activity of 3xFLAG-tagged PP2A C, PP4 C, and PP6 C, immunopurified from U2OS parental or CYB5R4 knockout stable cell lines. The data is representative of three independent experiments. G) Peptide dephosphorylation assays measuring the activity of HA-Pph21, myc-Pph3, and HA-Sit4 immunopurified from endogenously tagged wildtype ( wt ) and irc21 deletion strains. Data is shown for three independent experiments, and error bars represent standard deviations.

Article Snippet: Lysates were cleared by centrifugation for 30 minutes at 14,000 g whereafter supernatants were incubated with Fab-trap beads (Proteintech) for immunoprecipitation of 3xFLAG control and 3xFLAG-conjugated catalytic subunits or with GFP-trap beads (Proteintech) for immunoprecipitation of venus-tagged CYB5R4 wild-type and mutant.

Techniques: Genome Wide, CRISPR, Knock-Out, Next-Generation Sequencing, Mass Spectrometry, De-Phosphorylation Assay, Activity Assay, Stable Transfection

A) Residue map of CYB5R4 showing synthetic lethality in OA. X-axis depicts the amino acid residue targeted for mutation and the y-axis the average log2 fold changes of gRNAs targeting the indicated residue in OA vs untreated conditions. The domains of CYB5R4 as well as H89R, H112R, and W114R are indicated. B) AlphaFold3 model of CYB5R4 with heme (salmon) and H89, H112, and W114 (yellow) indicated. C) Deep sequencing of the endogenous CYB5R4locus after transduction with a single gRNA targeting H112, followed by CRISPResso2 analysis shows the frequency of mutated alleles. Reference: the genomic sequence. The gRNA, PAM, and editing window are indicated as well as the amino acid translation. D) A colony formation assay was conducted in presence or absence of 2 nM OA with U2OS parental or CYB5R4 knockout cells. Cells were stably complemented with full length CYB5R4-venus either wildtype (WT) or with the specified mutations. The survival is calculated as the relative number of colonies in OA to untreated and represents three independent experiments. Error bares depict standard deviations and the shown p -values are based on one-way ANOVA analysis with Tukey’s multiple comparisons test.

Journal: bioRxiv

Article Title: A functional map of phosphoprotein phosphatase regulation identifies an evolutionary conserved reductase for the catalytic metal ions

doi: 10.1101/2025.02.12.637884

Figure Lengend Snippet: A) Residue map of CYB5R4 showing synthetic lethality in OA. X-axis depicts the amino acid residue targeted for mutation and the y-axis the average log2 fold changes of gRNAs targeting the indicated residue in OA vs untreated conditions. The domains of CYB5R4 as well as H89R, H112R, and W114R are indicated. B) AlphaFold3 model of CYB5R4 with heme (salmon) and H89, H112, and W114 (yellow) indicated. C) Deep sequencing of the endogenous CYB5R4locus after transduction with a single gRNA targeting H112, followed by CRISPResso2 analysis shows the frequency of mutated alleles. Reference: the genomic sequence. The gRNA, PAM, and editing window are indicated as well as the amino acid translation. D) A colony formation assay was conducted in presence or absence of 2 nM OA with U2OS parental or CYB5R4 knockout cells. Cells were stably complemented with full length CYB5R4-venus either wildtype (WT) or with the specified mutations. The survival is calculated as the relative number of colonies in OA to untreated and represents three independent experiments. Error bares depict standard deviations and the shown p -values are based on one-way ANOVA analysis with Tukey’s multiple comparisons test.

Article Snippet: Lysates were cleared by centrifugation for 30 minutes at 14,000 g whereafter supernatants were incubated with Fab-trap beads (Proteintech) for immunoprecipitation of 3xFLAG control and 3xFLAG-conjugated catalytic subunits or with GFP-trap beads (Proteintech) for immunoprecipitation of venus-tagged CYB5R4 wild-type and mutant.

Techniques: Residue, Mutagenesis, Sequencing, Transduction, Colony Assay, Knock-Out, Stable Transfection

A) Heatmap comparing the interactomes of venus-tagged CYB5R4 1-153 wildtype (WT), H89A/H112A, and W114A to venus control, which were immunoprecipitated from HeLa cells and analysed by mass spectrometry. PP4/6 holoenzyme components are shown. Colors represent log2 fold changes with red being increased and blue depleted compared to venus control. B) AlphaFold3 model of CYB5R4 1-153 and PP6 C with heme and residues H89, H112 and W114 indicated. The N-terminal tail of CYB5R4 is not shown in the close-up views for clarity. C) AlphaFold3 model of PP6 with annotation of CYB5R4 1-153 contacts (left) and a color gradient (right) that represents the average log2 fold changes of gRNAs targeting the indicated residue in OA vs untreated conditions. Blue values specify that mutation of the target residue causes depletion (synthetic lethality) in OA and red enrichment. Grey specifies residues not targeted. D) DiFMUP dephosphorylation assay measuring the activity of purified PP6 holoenzyme in presence or absence of pre-reduced purified CYB5R4 1-153 WT or H89A/H112A. Data is from three independent experiments, and error bars represent standard deviations. E) DiFMUP dephosphorylation assay measuring the activity of purified PP6 holoenzyme in presence or absence of the indicated reducing agents at 1 mM. Data is from three independent experiments, and error bars represent standard deviations. F) DiFMUP dephosphorylation assay measuring the activity of purified PP6 holoenzyme, which was first pre-incubated with or without EDTA to extract metal ions. Next, the enzyme was incubated in presence or absence of Mn 2+ and finally in the presence or absence of pre-reduced purified CYB5R4 1-153 WT. Activity after 30 minutes is shown (also see Supplementary Figure S7F). Data is from three independent experiments, and error bars represent standard deviations. G) Model of PP4/6 regulation by CYB5R4.

Journal: bioRxiv

Article Title: A functional map of phosphoprotein phosphatase regulation identifies an evolutionary conserved reductase for the catalytic metal ions

doi: 10.1101/2025.02.12.637884

Figure Lengend Snippet: A) Heatmap comparing the interactomes of venus-tagged CYB5R4 1-153 wildtype (WT), H89A/H112A, and W114A to venus control, which were immunoprecipitated from HeLa cells and analysed by mass spectrometry. PP4/6 holoenzyme components are shown. Colors represent log2 fold changes with red being increased and blue depleted compared to venus control. B) AlphaFold3 model of CYB5R4 1-153 and PP6 C with heme and residues H89, H112 and W114 indicated. The N-terminal tail of CYB5R4 is not shown in the close-up views for clarity. C) AlphaFold3 model of PP6 with annotation of CYB5R4 1-153 contacts (left) and a color gradient (right) that represents the average log2 fold changes of gRNAs targeting the indicated residue in OA vs untreated conditions. Blue values specify that mutation of the target residue causes depletion (synthetic lethality) in OA and red enrichment. Grey specifies residues not targeted. D) DiFMUP dephosphorylation assay measuring the activity of purified PP6 holoenzyme in presence or absence of pre-reduced purified CYB5R4 1-153 WT or H89A/H112A. Data is from three independent experiments, and error bars represent standard deviations. E) DiFMUP dephosphorylation assay measuring the activity of purified PP6 holoenzyme in presence or absence of the indicated reducing agents at 1 mM. Data is from three independent experiments, and error bars represent standard deviations. F) DiFMUP dephosphorylation assay measuring the activity of purified PP6 holoenzyme, which was first pre-incubated with or without EDTA to extract metal ions. Next, the enzyme was incubated in presence or absence of Mn 2+ and finally in the presence or absence of pre-reduced purified CYB5R4 1-153 WT. Activity after 30 minutes is shown (also see Supplementary Figure S7F). Data is from three independent experiments, and error bars represent standard deviations. G) Model of PP4/6 regulation by CYB5R4.

Article Snippet: Lysates were cleared by centrifugation for 30 minutes at 14,000 g whereafter supernatants were incubated with Fab-trap beads (Proteintech) for immunoprecipitation of 3xFLAG control and 3xFLAG-conjugated catalytic subunits or with GFP-trap beads (Proteintech) for immunoprecipitation of venus-tagged CYB5R4 wild-type and mutant.

Techniques: Control, Immunoprecipitation, Mass Spectrometry, Residue, Mutagenesis, De-Phosphorylation Assay, Activity Assay, Purification, Incubation